✦ LIBER ✦
A phase I study evaluating the role of the anti-epidermal growth factor receptor (EGFR) antibody cetuximab as a radiosensitizer with chemoradiation for locally advanced pancreatic cancer
✍ Scribed by J. P. Arnoletti; A. Frolov; M. Eloubeidi; K. Keene; J. Posey; T. Wood; Edward Greeno; N. Jhala; S. Varadarajulu; S. Russo; J. Christein; R. Oster; D. J. Buchsbaum; S. M. Vickers
- Publisher
- Springer
- Year
- 2010
- Tongue
- English
- Weight
- 369 KB
- Volume
- 67
- Category
- Article
- ISSN
- 0344-5704
No coin nor oath required. For personal study only.